| Bioactivity | 4’,5’-Didehydro-2’-O-(2-methoxyethyl)-5-methyluridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 4’,5’-Didehydro-2’-O-(2-methoxyethyl)-5-methyluridine |
| CAS | 2095417-31-3 |
| Formula | C13H18N2O6 |
| Molar Mass | 298.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
4’,5’-Didehydro-2’-O-(2-methoxyethyl)-5-methyluridine
CAS: 2095417-31-3 F: C13H18N2O6 W: 298.29
4’,5’-Didehydro-2’-O-(2-methoxyethyl)-5-methyluridine is a purine nucleoside analog. Purine nucleoside analogs have b
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.